David H Ellis
Overview
Explore the profile of David H Ellis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kidd S, Hagen F, Halliday C, Abdolrasouli A, Boekhout T, Crous P, et al.
J Clin Microbiol
. 2024 Mar;
62(4):e0157023.
PMID: 38441055
No abstract available.
2.
Coad B, Kidd S, Ellis D, Griesser H
Biotechnol Adv
. 2013 Nov;
32(2):296-307.
PMID: 24211473
Microbial attachment onto biomedical devices and implants leads to biofilm formation and infection; such biofilms can be bacterial, fungal, or mixed. In the past 15 years, there has been an...
3.
Gordon C, Whiting S, Haran G, Ward A, Coleman M, Baird R, et al.
Pathology
. 2012 May;
44(4):375-9.
PMID: 22565326
No abstract available.
4.
Dennerstein G, Ellis D, Reed C, Bennett C
J Low Genit Tract Dis
. 2010 Dec;
15(1):33-6.
PMID: 21192174
Objective: It is hypothesized that vaginal non-albicans yeasts (NAYs) do not require treatment. The objective was to determine whether women (presenting with a range of vulvovaginal complaints) found to be...
5.
6.
Chen S, Biswas C, Bartley R, Widmer F, Pantarat N, Obando D, et al.
Antimicrob Agents Chemother
. 2010 Jun;
54(8):3233-40.
PMID: 20530227
Ten bis(alkylpyridinium)alkane compounds were tested for antifungal activity against 19 species (26 isolates) of yeasts and molds. We then determined the MICs and minimum fungicidal concentrations (MFCs) of four of...
7.
Slavin M, Sorrell T, Marriott D, Thursky K, Nguyen Q, Ellis D, et al.
J Antimicrob Chemother
. 2010 Mar;
65(5):1042-51.
PMID: 20202987
Background: Candidaemia in cancer patients is associated with increasing fluconazole resistance. Models for predicting such isolates and their clinical impact are required. Methods: Clinical, treatment and outcome data from a...
8.
Stewardson A, Holmes N, Ellis D, Howden B
Mycoses
. 2009 Aug;
52(6):547-9.
PMID: 19682315
We describe a case of cutaneous zygomycosis caused by Saksenaea vasiformis in an immunocompetent 24-year-old woman. Diagnosis was based on histological and microbiological examination. The patient made a complete recovery...
9.
Obando D, Pantarat N, Handke R, Koda Y, Widmer F, Djordjevic J, et al.
Bioorg Med Chem
. 2009 Aug;
17(17):6329-39.
PMID: 19665385
A series of bis(alkylpyridinium)alkanes with a twelve carbon spacer between the positive charges was synthesised and their antifungal activity has been investigated. Compounds with 2-pentyl, 4-pentyl, 4-hexyl, 4-octyl, 4-propylbenzene, 3,4-dipentyl,...
10.
Kesson A, Bellemore M, OMara T, Ellis D, Sorrell T
Clin Infect Dis
. 2009 Mar;
48(9):1257-61.
PMID: 19320594
We describe an 8-year-old girl who sustained multiple compound fractures in an accident involving agricultural equipment. She developed Scedosporium prolificans osteomyelitis of the pelvis, septic arthritis of the hip, and...